Licensor Materials Sample Clauses

Licensor Materials. “Licensor Materials” means any software, programs, tools, systems, data, or other materials made available by Licensor to Licensee in the course of the performance under this Agreement including, but not limited to, the Software and Documentation, as well as any information, materials or feedback provided by Licensee to Licensor relating to the Software and Documentation.
Sample 1Sample 2
AutoNDA by SimpleDocs
Licensor Materials. Upon Bayer's request, Licensor will use Commercially Reasonable Efforts to assist Bayer in its obtaining from Selexis of Materials necessary for Bayer to have Antibodies Manufactured for it; provided that Bayer shall pay or reimburse Licensor for its reasonable out-of-pocket costs and expenses in providing such assistance.
Sample 1
Licensor Materials. 1. All cells lines, culture media and purification processes used for producing AR-101 and AR-301. (This includes commercially viable CHO cell line, scalable, high yield processes for cGMP manufacturing, and improved stable formulation).
Sample 1
Licensor Materials. The quantities of [***] provided by Licensor to Licensee under this Agreement. SCHEDULE 1.25 Licensor Patent Rights [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] SCHEDULE 5.1.1 List of Countries and Territories
Sample 1
Licensor Materials. 1. All cells lines, culture medium and purification processes used for producing XX-000, XX-000 and AR-301. (This includes commercially viable CHO cell line, the identity of the culture medium formula used for manufacturing, scalable, high yield processes for cGMP manufacturing, and improved stable formulation).
Sample 1
Licensor Materials. Compounds Present Inventory: Licensor will provide Merck with the Drug Product vials [**]. The bulk API will be provided to Merck against reimbursement by Merck of the costs which Idera had incurred [**]. Merck will elect in writing within [**] days after Effective Date if and to what extent bulk API shall be transferred to Merck. Such election shall be in [**] gram quantities. [**] Approximately [**] grams bulk API Approximately [**] [**]mg Drug Product vials Follow-On Compounds Licensor will provide Merck with up to [**]mg of each Follow-On Compound at time of transfer to Merck pursuant to Section 3.6, [**] to Merck. IDP Compound # Sequence Modifications [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**]. Schedule 1.38 Licensor Patents Idera Number: Docket # Continuation PCT Nationalization County Title: Status Application Number Application Date Patent /Publication Number Grant Date [**] Confidential materials omitted and filed separately with the Securities and Exchange Commission. A total of 7 pages have been omitted. Schedule 2.3 Initial Technology Transfer Technology Transfer Plan — IMO-2055 & IMO-2125 [**] Schedule 2.4 Manufacturing Technology Transfer Manufacturing Technology Transfer Plan — IMO-2055 & IMO-2125 [**] Schedule 3.3 On-Going Trials Budget Theradex® Study Budget — IDP 2055-200 (NSCLC) — Payment Schedule. [**] Confidential materials omitted and filed separately with the Securities and Exchange Commission. A total of 17 pages have been omitted. Schedule 6.5 Patent Countries [**] Schedule 7.3.1 Idera Press Release Contacts: Idera Pharmaceuticals, Inc. MxxXxxxxxx Biomedical Communications Kxxxx Xxxxxxx Cxxxx Xxxxxx 600-000-0000 500-000-0000 E-mail: kxxxxxxx@xxxxxxxxxxx.xxx E-mail: cxxxxxx@xxxxxxxxx.xxx Idera Pharmaceuticals and Merck KGaA to Collaborate on Development of TLR9 Agonists for Treatment of Cancer Cambridge, MA, December XX, 2007 — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced today that it has entered into a worldwide licensing and collaboration agreement with Merck KGaA of Darmstadt, Germany, for the research, development and commercialization of Idera’s Toll-like Receptor 9 (TLR9) agonists for the treatment of cancer. Under the agreement, Idera has agreed to exclusively license the therapeutic oncology applications, excluding cancer vaccines, of its lead TLR9 agonists, IMO-2055 and IMO-2125. In addition, Idera and Merck KGaA have agreed to engage in a research collaboration t...
Sample 1
Licensor Materials. Licensor agrees to provide Knight from time to time with all marketing and sales materials used by Licensor or its licensees outside the Territory for the Licensed Products, in all cases only to the extent Licensor Controls such materials, and Knight shall [***] to the extent Licensor has the right to grant such right to Knight.
Sample 1
AutoNDA by SimpleDocs
Licensor Materials 
Sample 1

Related to Licensor Materials

  • Third Party Materials The Application may display, include, or make available third-party content (including data, information, applications, and other products, services, and/or materials) or provide links to third-party websites or services, including through third- party advertising ("Third-Party Materials"). You acknowledge and agree that Company is not responsible for Third-Party Materials, including their accuracy, completeness, timeliness, validity, copyright compliance, legality, decency, quality, or any other aspect thereof. Company does not assume and will not have any liability or responsibility to you or any other person or entity for any Third-Party Materials. Third-Party Materials and links thereto are provided solely as a convenience to you, and you access and use them entirely at your own risk and subject to such third parties' terms and conditions.

  • Operator Materials Operator retains all right, title and interest in and to any and all of Operator’s software, materials, tools, forms, documentation, training and implementation materials and intellectual property (“Operator Materials”). Operator grants to the LEA a personal, nonexclusive license to use the Operator Materials for its own non-commercial, incidental use as set forth in the Service Agreement. Operator represents that it has all intellectual property rights necessary to enter into and perform its obligations in this DPA and the Service Agreement, warrants to the District that the District will have use of any intellectual property contemplated by the Service Agreement free and clear of claims of any nature by any third Party including, without limitation, copyright or patent infringement claims, and agrees to indemnify the District for any related claims.

  • Customer Materials 11.1. The Supplier including any of its employees, agents, consultants, contractors and any third party shall:

  • Licensed Materials The materials that are the subject of this Agreement are set forth in Appendix A ("Licensed Materials").

  • Licensed Technology The term “Licensed Technology” shall mean the Licensed Patent Rights, Licensed Know-How and Licensed Biological Materials.

  • Technical Information The Employer agrees to provide to the Union such information that is available relating to employees in the bargaining unit, as may be required by the Union for collective bargaining purposes.

  • Product Information Contractor shall provide the following information for all goods provided pursuant to this Agreement: manufacturer’s name, product code number, and pack size.

  • Licensed Software Computer program(s) provided by Contractor in connection with the Deliverables, subject to Section 14 of this Contract.

  • Third Party Technology Customer is hereby notified that third parties have licensed certain technology to Company, which is contained in the Software. Notwithstanding anything herein to the contrary, Customer hereby consents to the disclosure of Customer’s identity, and such other terms of this Agreement as necessary, to such third party licensors for the purpose of enabling Company to comply with the terms and conditions of such third party licenses. Any such Customer information will be provided pursuant to an obligation of confidentiality and nondisclosure at least as stringent as that imposed by this Agreement.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

Time is Money Join Law Insider Premium to draft better contracts faster.